Q2 2024 Earnings Estimate for Celsius Holdings, Inc. Issued By Wedbush (NASDAQ:CELH)

Celsius Holdings, Inc. (NASDAQ:CELH) – Wedbush reduced their Q2 2024 EPS estimates for shares of Celsius in a note issued to investors on Tuesday, May 7th. Wedbush analyst G. Pascarelli now expects that the company will earn $0.25 per share for the quarter, down from their prior estimate of $0.26. Wedbush currently has a “Outperform” rating and a $100.00 target price on the stock. The consensus estimate for Celsius’ current full-year earnings is $1.09 per share. Wedbush also issued estimates for Celsius’ Q3 2024 earnings at $0.29 EPS, Q4 2024 earnings at $0.23 EPS, FY2024 earnings at $1.04 EPS, Q1 2025 earnings at $0.26 EPS, Q2 2025 earnings at $0.31 EPS, Q3 2025 earnings at $0.38 EPS, Q4 2025 earnings at $0.30 EPS and FY2025 earnings at $1.26 EPS.

Celsius (NASDAQ:CELH) last announced its earnings results on Tuesday, May 7th. The company reported $0.27 EPS for the quarter, topping the consensus estimate of $0.20 by $0.07. Celsius had a net margin of 17.21% and a return on equity of 131.58%. The business had revenue of $355.70 million during the quarter, compared to the consensus estimate of $390.37 million. During the same quarter in the previous year, the firm posted $0.13 EPS. Celsius’s revenue was up 36.9% compared to the same quarter last year.

A number of other research firms also recently issued reports on CELH. Stifel Nicolaus cut their price objective on shares of Celsius from $95.00 to $85.00 and set a “buy” rating for the company in a report on Thursday, May 2nd. Piper Sandler increased their price target on Celsius from $76.00 to $90.00 and gave the stock an “overweight” rating in a research report on Friday, March 1st. Jefferies Financial Group lifted their price objective on Celsius from $98.00 to $105.00 and gave the company a “buy” rating in a report on Monday, March 18th. Maxim Group increased their target price on Celsius from $100.00 to $110.00 and gave the stock a “buy” rating in a report on Monday, April 1st. Finally, Bank of America cut shares of Celsius from a “buy” rating to a “neutral” rating and set a $65.00 price objective for the company. in a research report on Friday, January 19th. Two investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $84.95.

Celsius Stock Performance

CELH opened at $77.13 on Thursday. Celsius has a fifty-two week low of $34.74 and a fifty-two week high of $99.62. The company has a market capitalization of $17.82 billion, a P/E ratio of 100.17, a P/E/G ratio of 2.22 and a beta of 1.93. The stock has a fifty day moving average of $81.42 and a 200-day moving average of $65.97.

Insider Buying and Selling

In related news, major shareholder William H. Milmoe sold 428,568 shares of Celsius stock in a transaction that occurred on Monday, April 29th. The stock was sold at an average price of $59.67, for a total value of $25,572,652.56. Following the transaction, the insider now directly owns 25,464,453 shares of the company’s stock, valued at $1,519,463,910.51. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. In related news, major shareholder William H. Milmoe sold 428,568 shares of the business’s stock in a transaction on Monday, April 29th. The shares were sold at an average price of $59.67, for a total value of $25,572,652.56. Following the transaction, the insider now owns 25,464,453 shares in the company, valued at $1,519,463,910.51. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director Nicholas Castaldo sold 165,000 shares of the stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $83.33, for a total value of $13,749,450.00. Following the sale, the director now owns 352,864 shares of the company’s stock, valued at $29,404,157.12. The disclosure for this sale can be found here. Insiders sold a total of 2,043,363 shares of company stock valued at $131,361,140 in the last three months. Insiders own 2.20% of the company’s stock.

Institutional Investors Weigh In On Celsius

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Cambridge Investment Research Advisors Inc. increased its position in Celsius by 89.1% in the 3rd quarter. Cambridge Investment Research Advisors Inc. now owns 16,386 shares of the company’s stock valued at $2,812,000 after buying an additional 7,723 shares in the last quarter. Raymond James Financial Services Advisors Inc. lifted its position in Celsius by 8.0% in the 3rd quarter. Raymond James Financial Services Advisors Inc. now owns 53,237 shares of the company’s stock valued at $9,135,000 after acquiring an additional 3,921 shares in the last quarter. Bank of New York Mellon Corp boosted its stake in Celsius by 8.5% during the 3rd quarter. Bank of New York Mellon Corp now owns 428,602 shares of the company’s stock valued at $73,548,000 after purchasing an additional 33,597 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in Celsius by 48.4% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 8,100 shares of the company’s stock worth $1,390,000 after purchasing an additional 2,643 shares in the last quarter. Finally, Advisor Partners II LLC raised its stake in shares of Celsius by 4.9% in the third quarter. Advisor Partners II LLC now owns 1,858 shares of the company’s stock worth $319,000 after purchasing an additional 87 shares during the last quarter. 60.95% of the stock is owned by institutional investors.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.